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accuracy. The end-to-end test procedure requires on average 
70 min preparation time, 30 min at the linear accelerator, 20 
min analysis and administration. It allows end-to-end testing 
to be performed more frequently to assure the accuracy over 
time.  
 
Conclusion: The developed end-to-end test is quick, cost-
effective and easy to implement clinically. It allows to 
frequently highlight geometrical inaccuracies in an image-
guided radiation therapy environment.  
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Purpose or Objective: The Global Harmonisation Group was 
created in 2009 to harmonise and improve the quality 
assurance (QA) of radiation therapy implemented worldwide 
in multi-institutional clinical trials. The aim is to achieve a 
consistent platform to provide and share QA processes in 
clinical trials such that the workload for both the institutions 
and the QA groups is reduced and streamlined. As part of this 
aim, the group reviewed their reporting techniques to better 
understand each other’s approaches and agree on core 
information which would be included as part of future 
creation of a standard template. This could potentially lead 
to the ability to use each other’s reports in lieu of 
unnecessary duplication 
 
Material and Methods: A survey was created to find a list of 
core information which could be included in future dosimetry 
credentialing reports. Answers were requested to give 
opinion from each group as to what should be included as a 
minimum in these reports. Some QA groups use site visits or 
postal phantoms, whereas some use a virtual phantom (i.e. 
local QA measurement) and others use both. The questions 
were divided to allow responses for both types. Questions 
were circulated amongst the groups beforehand and all 
comments and contributions were incorporated. 
 
Results: All seven current member groups replied. Results 
were divided into three categories, 1)information which all 
groups agreed should be included 2)information which the 
majority use and the others often use which could be 
discussed as being agreed on inclusion and 3)information 
which was not used by all groups, but which could be used by 
those who did (see table 1). 
 
Table 1 Agreed information in clinical trial QA group reports 
 
Conclusion: The survey showed that that there is a wide 
variation in the information currently provided in the reports 
from the various QA organisations, which may hamper their 
mutual acceptance. Following discussion there were several 
pieces of information which were agreed should always be 
included and these constitute the beginning of an agreed list 
of included core information. There are several more pieces 
of information which the majority always include and the 
others use often or sometimes. These could be discussed to 
understand when and why they are not used and perhaps 
considered for inclusion. There are some others where not all 
members use the information because they do not use a 
gamma index analysis, however these could be included for 
those who do use the gamma index. There is also some 
information which sometimes included, but which is always 
included when needed. These cases will be discussed and 
decided if these should be included in specific cases, perhaps 
including a flowchart to aid standardisation. Some groups 
have already reviewed or are in the process of reviewing 
their reports to ensure inclusion of core information. 
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Purpose or Objective: To present an overview and the 
current status of Novalis Certification, which provides a 
comprehensive and independent assessment of safety and 
quality in stereotactic radiosurgery (SRS) and stereotactic 
body radiation therapy (SBRT), ensuring the highest standards 
and consistency of practice. 
 
Material and Methods: The Novalis Certification program 
includes a review of SRS/SBRT program structure, adequacy 
of personnel resources and training, appropriateness and use 
of technology, program quality management, patient-specific 
quality assurance and equipment quality control. Currently 
ten auditors support the program, with six in North America, 
three in Europe and one in Asia, each bringing a minimum of 
a decade of experience in stereotactic practice. Centres 
applying for Novalis Certification complete a self-study 30 
days prior to a scheduled one-day site visit by one to two 
reviewers. Reviewers generate a descriptive 77-point report 
which is reviewed and voted on by a multidisciplinary expert 
panel of 3 medical physicists, 2 radiation oncologists and 2 
neurosurgeons. Outcomes of reviews may include mandatory 
